SMW Free Realtime Trade Alerts -- Fast Moving Stocks < $15 -- Join Today for FREE!!

Alcobra Ltd.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
Loading ADHD News...
Health Technology » Pharmaceuticals Other
VRXValeant Pharmaceuticals International, Inc.
SHPGShire PLC Sponsored ADR
PRGOPerrigo Co. Plc
ENDPEndo International Plc
GWPHGW Pharmaceuticals PLC Sponsored ADR
MNKMallinckrodt Plc
UTHRUnited Therapeutics Corporation
JAZZJazz Pharmaceuticals Plc
ICPTIntercept Pharmaceuticals, Inc.
MDCOMedicines Company
HZNPHorizon Pharma plc
DEPODepomed, Inc.
AERIAerie Pharmaceuticals, Inc.
CTLTCatalent Inc

Company Profile

Alcobra Ltd. engages in the research, development, and market of pharmaceutical productsfor the treatment of central nervous system disorders and cognitive dysfunctions. Its portfolio includes Metadoxine Extended Release to treat Attention Deficit Hyperactivity Disorder and Fragile X Syndrome. The company was founded by Ehud Moshe Gilboa and Dalia Megiddo on February 7, 2008 and is headquartered in Tel Aviv, Israel.